Login Register Cart 0
Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Local Delivery of Metronidazole-loaded N-Trimethyl Quaternary Ammonium Chitosan Nanoparticles for Periodontitis Treatment

Author(s): Kritika Garg* and Pravin Tirgar

Volume 17, Issue 4, 2022

Published on: 05 July, 2022

Page: [233 - 265] Pages: 33

DOI: 10.2174/1574885517666220331145439

Price: $65

Abstract

Background: Recent findings suggest that chitosan has shown antibacterial activity acting through various mechanisms, but when the amine group in chitosan is converted to quaternary ammonium compound, the antibacterial activity of chitosan is elevated due to the increase in its solubility in an acidic environment.

Objectives: The purpose of this study was to formulate and standardize metronidazole-loaded Ntrimethyl quaternary ammonium chitosan nanoparticles for the treatment of periodontitis.

Method: N-trimethyl quaternary ammonium chitosan derivative was synthesized, and nanoparticles (NPs) were prepared by ionic gelation methodology followed by 32 full factorial designs. Particle size, zeta potential, polydispersity index (PDI), surface morphology, thermal properties, in vitro drug release as well as antimicrobial activity, stability study, ex vivo, and acute toxicity of NPs were evaluated.

Results: The optimized batches of NPs were in the size range of 150 to 237 nm with a mean size of 117.01 ± 0.03 nm. Entrapment efficiency (EE) of 81.45 ± 0.03 % was obtained with a zeta potential (mV) of 28.19 ± 0.03 mV. Almost 98.97 ± 7.17% of the drug was released within 24 hours in vitro to obtain a sustained release drug; the optimized batches exhibited a smooth surface with appreciable in vitro, ex vivo antibacterial, and acute toxicity, and it was found that the formulation could be stored for up to 6 months.

Conclusion: The present study revealed that metronidazole-loaded N-trimethyl quaternary ammonium chitosan nanoparticles exhibit enhanced antibacterial activity against periodontal infections.

Keywords: N-trimethylquaternary ammonium chitosan derivative, nanoparticles, periodontitis, targeted drug delivery system, controlled drug delivery, periodontal pocket, 32 full factorial design, enhanced treatment.

« Previous Next »
Graphical Abstract

[1]
Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004; 34(1): 9-21.
[http://dx.doi.org/10.1046/j.0906-6713.2002.003421.x] [PMID: 14717852]
[2]
Jordan RC. Diagnosis of periodontal manifestations of systemic diseases. Periodontol 2000 2004; 34(1): 217-29.
[http://dx.doi.org/10.1046/j.0906-6713.2002.003433.x] [PMID: 14717864]
[3]
Albandar JM, Rams TE. Global epidemiology of periodontal diseases: An overview. Periodontol 2000 2002; 29(1): 7-10.
[http://dx.doi.org/10.1034/j.1600-0757.2002.290101.x] [PMID: 12102700]
[4]
Löe H, Anerud A, Boysen H, Morrison E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 1986; 13(5): 431-45.
[http://dx.doi.org/10.1111/j.1600-051X.1986.tb01487.x] [PMID: 3487557]
[5]
Löe H, Anerud A, Boysen H, Smith M. The natural history of periodontal disease in man. The rate of periodontal destruction before 40 years of age. J Periodontol 1978; 49(12): 607-20.
[http://dx.doi.org/10.1902/jop.1978.49.12.607] [PMID: 282430]
[6]
van Palenstein Helderman WH, Joarder MA, Begum A. Prevalence and severity of periodontal diseases and dental caries in Bangladesh. Int Dent J 1996; 46(2): 76-81.
[PMID: 8930677]
[7]
Ronderos M, Pihlstrom BL, Hodges JS. Periodontal disease among indigenous people in the Amazon rain forest. J Clin Periodontol 2001; 28(11): 995-1003.
[http://dx.doi.org/10.1034/j.1600-051X.2001.281102.x] [PMID: 11686819]
[8]
Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999; 70(1): 13-29.
[http://dx.doi.org/10.1902/jop.1999.70.1.13] [PMID: 10052767]
[9]
Shaju JP, Zade RM, Das M. Prevalence of periodontitis in the Indian population: A literature review. J Indian Soc Periodontol 2011; 15(1): 29-34.
[http://dx.doi.org/10.4103/0972-124X.82261] [PMID: 21772718]
[10]
Cobb CM. Clinical significance of non-surgical periodontal therapy: An evidence-based perspective of scaling and root planing. J Clin Periodontol 2002; 29(Suppl. 2): 6-16.
[http://dx.doi.org/10.1034/j.1600-051X.29.s2.4.x] [PMID: 12010523]
[11]
Cobb CM. Non-surgical pocket therapy: Mechanical. Ann Periodontol 1996; 1(1): 443-90.
[http://dx.doi.org/10.1902/annals.1996.1.1.443] [PMID: 9118268]
[12]
Suvan JE. Effectiveness of mechanical nonsurgical pocket therapy. Periodontol 2000 2005; 37(1): 48-71.
[http://dx.doi.org/10.1111/j.1600-0757.2004.03794.x] [PMID: 15655025]
[13]
Drisko CH. Nonsurgical periodontal therapy. Periodontol 2000 2001; 25(1): 77-88.
[http://dx.doi.org/10.1034/j.1600-0757.2001.22250106.x] [PMID: 11155183]
[14]
Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003; 8(1): 115-81.
[http://dx.doi.org/10.1902/annals.2003.8.1.115] [PMID: 14971252]
[15]
Hung HC, Douglass CW. Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol 2002; 29(11): 975-86.
[http://dx.doi.org/10.1034/j.1600-051X.2002.291102.x] [PMID: 12472990]
[16]
Preshaw PM, Hefti AF, Novak MJ, et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: A multicenter trial. J Periodontol 2004; 75(8): 1068-76.
[http://dx.doi.org/10.1902/jop.2004.75.8.1068] [PMID: 15455733]
[17]
Hanes PJ, Purvis JP. Local anti-infective therapy: Pharmacological agents. A systematic review. Ann Periodontol 2003; 8(1): 79-98.
[http://dx.doi.org/10.1902/annals.2003.8.1.79] [PMID: 14971250]
[18]
Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990; 17(7 (Pt 2)): 479-93.
[http://dx.doi.org/10.1111/j.1365-2710.1992.tb01220.x] [PMID: 2202744]
[19]
Vandekerckhove BNA, Quirynen M, van Steenberghe D. The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J Periodontol 1997; 68(4): 353-61.
[http://dx.doi.org/10.1902/jop.1997.68.4.353] [PMID: 9150040]
[20]
Pitcher GR, Newman HN, Strahan JD. Access to subgingival plaque by disclosing agents using mouthrinsing and direct irrigation. J Clin Periodontol 1980; 7(4): 300-8.
[http://dx.doi.org/10.1111/j.1600-051X.1980.tb01972.x] [PMID: 6936408]
[21]
Gates KA, Grad H, Birek P, Lee PI. A new bioerodible polymer insert for the controlled release of metronidazole. Pharm Res 1994; 11(11): 1605-9.
[http://dx.doi.org/10.1023/A:1018913921956] [PMID: 7870678]
[22]
Greenstein G. Local drug delivery in the treatment of periodontal diseases: Assessing the clinical significance of the results. J Periodontol 2006; 77(4): 565-78.
[http://dx.doi.org/10.1902/jop.2006.050140] [PMID: 16584336]
[23]
Yao W, Xu P, Pang Z, et al. Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs. Int J Nanomedicine 2014; 9: 3963-70.
[http://dx.doi.org/10.2147/IJN.S67521] [PMID: 25170266]
[24]
Tee YN, Kumar PV, Maki MAA, Elumalai M, Rahman SAKMEH, Cheah SC. Mucoadhesive low molecular chitosan complexes to protect rHuKGF from proteolysis: In-vitro characterization and FHs 74 int cell proliferation studies. Curr Pharm Biotechnol 2021; 22(7): 969-82.
[http://dx.doi.org/10.2174/1389201021666201218124450] [PMID: 33342408]
[25]
Kumar PV, Maki MAA, Wei YS, et al. Rabbit as an animal model for pharmacokinetics studies of enteric capsule contains recombinant human keratinocyte growth factor loaded chitosan nanoparticles. Curr Clin Pharmacol 2019; 14(2): 132-40.
[http://dx.doi.org/10.2174/1574884714666181120103907] [PMID: 30457053]
[26]
Kumar PV, Maki MAA, Takahje ML, et al. Detection of formation of recombinant human keratinocyte growth factor loaded chitosan nanoparticles based on its optical properties. Curr Nanosci 2018; 14(2): 127-35.
[http://dx.doi.org/10.2174/1573413713666171016150707]
[27]
Fai KT, Yee GH, Kumar PV, Elumalai M. Preparation of chitosan particles as a delivery system for tetrahydrocurcumin: β-cyclodextrin inclusive compound for colorectal carcinoma. Curr Drug Ther 2021; 16(5): 16.
[http://dx.doi.org/10.2174/1574885516666211210153741]
[28]
Luan F, Wei L, Zhang J, et al. Preparation and characterization of quatrnized chitosan derivatives and assessment of their antioxidant activity. Molecules 2018; 23(3): 1-13.
[http://dx.doi.org/10.3390/molecules23030516] [PMID: 29495379]
[29]
Debnath S, Kumar RS, Babu MN. Ionotropic gelation – A novel method to prepare chitosan nanoparticles. Res J Pharm Tech 2011; 4(4): 492-5.
[http://dx.doi.org/10.5958/0974-360X]
[30]
Kunjachan S, Jose S, Lammers T. Understanding the mechanism of ionic gelation for synthesis of chitosan nanoparticles using qualitative technique. Asian J Pharm 2010; 148-53.
[http://dx.doi.org/10.22377/AJP.V4I2.220]
[31]
Hanafy AS, Farid RM, ElGamal SS. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for alzheimer’s disease management: Preparation and detection in rat brain. Drug Deve Ind Pharmacy 2015; 41(12): 2055-68.
[http://dx.doi.org/10.3109/03639045.2015.1062897] [PMID: 26133084]
[32]
Sreeharsha N, Rajpoot K, Tekade M, et al. Development of metronidazole loaded chitosan nanoparticles using QbD approach – a novel and potential antibacterial formulation. Pharmaceutics 2020; 12(10): 1-22.
[http://dx.doi.org/10.3390/pharmaceutics12100920] [PMID: 32992903]
[33]
Tiruwa R. A review on nanoparticles – preparation and evaluation parameters. Ind J Pharmaceu Bio Res 2016; 4(2): 27-31.
[http://dx.doi.org/10.30750/ijpbr.4.2.4]
[34]
Nagarwal RC, Kumar R, Pandit JK. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: In vitro characterization and in vivo study in rabbit eye. Eur J Pharm Sci 2012; 47(4): 678-85.
[http://dx.doi.org/10.1016/j.ejps.2012.08.008] [PMID: 22922098]
[35]
Pandey S, Das U, Patil A. Formulation and ex-vivo evaluation of mitronidazole microemulsion loaded hydrogel for prevention of periodontitis. J Pharmaceu Inv 2014; 2014: 7690184.
[http://dx.doi.org/10.1007/s40005-014-0119-2]
[36]
OECD/OCDE. Acute oral toxicity: Up and down procedure, guideline for the testing of chemicals Section 4. OECD. 2008; 25: 1-27.
[http://dx.doi.org/10.1787/9789264071049-en]

Rights & Permissions Print Cite
Article Metrics
21
4
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy